Editorial introductions : Current Opinion in Allergy and Clinical Immunology

Secondary Logo

Journal Logo


Editorial introductions

Editor(s): Milgrom, Henry; Gómez, René Maximiliano; Ebisawa, Motohiro; Fiocchi, Alessandro

Current Opinion in Allergy and Clinical Immunology 23(3):p v-vi, June 2023. | DOI: 10.1097/ACI.0000000000000907
  • Free

Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.


Henry Milgrom

Henry Milgrom

Dr Milgrom has been on the staff National Jewish Health in Denver, USA for 32 years. He is Professor Emeritus of Pediatrics at the University of Colorado School of Medicine, USA. Dr Milgrom believes that the challenge for healthcare in the 21st century is to provide proficient and cost-effective health management, especially as it pertains to chronic illness.

Dr Milgrom believes that outcomes research, or comparative effectiveness research (CER), advances the understanding of the effectiveness, benefits, and harms of diverse treatment strategies. He feels such understanding is particularly important in conditions where cure may not be achievable, and the quality of life is the most important end point. Electronic health records provide a vast quantity of data for analytics, enabling providers to establish evidence-based best practices.

A significant proportion of healthcare expenditures is used for interventions with uncertain efficacy. Patterns of care vary widely, and evidence-based insight is often lacking. Providers too often rely on their individual knowledge and judgment rather than to draw on a wider range of evidence and experience. Dr Milgrom believes that the goals of all healthcare providers should include better clinical results and improved patient health. The challenge is to threaten precedent and make it our business to base patient care on actionable insights. All of us have a stake in this endeavour and all of us should participate.

René Maximiliano Gómez

René Maximiliano Gómez

Dr René Maximiliano Gómez gained his medical degree in 1991 at the Catholic University of Córdoba, Argentina, and he presented his PhD thesis there in May 2016. He is a board-certified specialist in Allergy and Immunology both at Argentinean Association of Allergy & Clinical Immunology and at the National University of Córdoba, Argentina, and a consultant in Allergy, Asthma & Immunology Unit at Alas Medical Institute in Salta, Argentina. He has worked as Medical Director at this last institution, and in the academic field as an invited professor in Immunology (Veterinary Sciences at the Catholic University of Salta) and Dermatology (Faculty of Medicine at the National University of Salta, Argentina). From April 2020 is the Director of School of Health Sciences at Catholic University of Salta, Argentina.

Dr Gómez is President of the Ayre Foundation, leading the education and research on allergy and respiratory diseases in Salta, Argentina, and member of the State Ethics’ Committee in Human Research.

He served as Scientific Secretary at the Latin American Society of Allergy, Asthma and Immunology (SLaai) in 2013 and held the post until 2017. He was General Secretary of SLaai 2017–18 and Scientific Director of Argentinean Association of Allergy & Clinical Immunology (AAAeIC) 2018–2019, being the President Elect of AAAeIC since 2019. He is also a committee member on allergy diagnosis and molecular allergology at the World Allergy Organization, and associate editor of WAO Journal. Dr Gómez has authored and co-authored about 50 peer reviewed publications. His research focuses on allergens and indoor pollution in asthma/allergic rhinitis, parasites and atopy, chronic urticaria, allergen immunotherapy and registries for allergic diseases.

Motohiro Ebisawa

Motohiro Ebisawa

Motohiro Ebisawa is the Director of Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital and the Professor of the Jikei University School of Medicine. He graduated from the Jikei University School of Medicine in Tokyo, Japan in 1985 and took short visiting resident course in the department of Pediatrics at St. Thomas Hospital in London, UK. He completed his postgraduate course at the Jikei University School of Medicine, where he earned his PhD. He did postdoctoral fellowship on the analysis of “eosinophil selective recruitment” in Dr Robert P. Schleimer's laboratory at Johns Hopkins University from 1991–1993. He also had a chance to visit Dr Hugh Sampson's food allergy unit regularly during his fellowship. After coming back to Japan, he started food allergy practice and research at Sagamihara National Hospital since 1995. He has published more than 250 papers on international journals in addition to numerous numbers on domestic ones.

He is a leading expert in food allergies in Japan and currently serves as the President of Japanese Society of Allergology (JSA) and Asian Pacific Academy of Pediatric Allergy, Respirology and Immunology (APAPARI). He is the Past President of WAO. He also serves as an associate editor of PAI, JACI G, and COACI.

Alessandro Fiocchi

Alessandro Fiocchi

Alessandro Fiocchi MD is the Director of Allergy at the Pediatric Hospital Bambino Gesù (OPBG), Rome, Vatican City. Formerly director of Pediatrics at the Melloni University Hospital in Milan, Italy, he is an expert in the field of food allergy. After post-graduate degrees and professional qualification in pediatrics, allergy medicine, pulmonology, and neonatology, he dedicated his research and clinical work to the care of children with asthma and allergic disease. Currently, he leads a research group focusing on food allergy, asthma, and specific immunotherapy. This group is based in the OPBG, a health care and research institution specialized in pediatric and developing ages. As the largest Pediatric Hospital in Italy, OPBG guarantees total coverage for all health care needs, including allergy.

Since 2001, he has organized international meetings in Milan, Italy, and other countries. He has founded and presides over the Italian Research Foundation for Allergy and Asthma in Childhood – Allegria ONLUS, a charity dedicated to clinical and research studies.

As chair of the Adverse Reactions to Foods Committee of the American College of Allergy, Asthma, and Immunology, he co-chaired several International Food Allergy Symposiums, the last in Anaheim, November 2012, with Sami Bahna and Amal Assa’ad. As chair of the Special Committee on Food Allergy of the World Allergy Organization (WAO), he worked with Hugh Sampson to co-chair both the WAO Food Allergy Symposium in Bangkok, 2007, and in Buenos Aires, 2009. Under his chairmanship, WAO published the Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines in 2010 and the Clinical Use of Probiotics in Pediatric Allergy (CUPPA) position paper on the use of probiotics in pediatric allergy. Since January 2014, Dr Fiocchi has been Editor-in-Chief of the World Allergy Organization Journal. His publications cover the fields of food allergy diagnosis, follow-up, epidemiology, specific immunotherapy and childhood asthma.

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.